Advertisement

Related Videos

David A. Hyman, MD, JD, on Inclusive Shared Savings

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Focus on Optimized Dosing of Ibrutinib Panel Discussion

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Mar
31
Today In Oncology
Molecular Test Doubles Detection of Bile Duct Cancer
‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?
Adjuvant Pembrolizumab Plus Belzutifan in Patients With RCC at Increased Risk of Recurrence
Risk of Subsequent Cancer in Solid Organ Transplant Recipients With Pretransplant Cancer History
Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo